Scott B. Ullem sold $806K of Edwards Lifesciences (EW)

Executed Dec 9 2024, disclosed Dec 9 2024, the same day.

Value, as filed

$806K

11,250 sh × $71.68

Executed

Dec 9 2024

the trade date, as filed

Disclosed

Dec 9 2024

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Scott B. Ullem CVP, Chief Financial Officer profile →

Scott B. Ullem (CVP, Chief Financial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Edwards Lifesciences Corporation (EW). The largest single filing was $1.1M of EW (13,000 sh across 2 lots, as filed), executed Mar 11.

The name

Edwards Lifesciences Corporation EW · Healthcare · 56 filings in 24 months ticker →

Healthcare · Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe,…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Scott B. Ullem in EW

EWSALE Edwards Lifesciences Corporation $1.0M
13,000 sh across 2 lots
Exec Apr 9
Filed Apr 9 · 5:30 PM ET EWSALE Edwards Lifesciences Corporation $1.1M
13,000 sh across 2 lots
Exec Mar 11
Filed Mar 11 · 5:30 PM ET EWSALE Edwards Lifesciences Corporation $650K
7,700 sh × $84.47
Exec Dec 9 2025
Filed Dec 9 2025 · 5:30 PM ET EWSALE Edwards Lifesciences Corporation $1.1M
13,000 sh across 2 lots
Exec Nov 10 2025
Filed Nov 10 2025 · 5:30 PM ET EWSALE Edwards Lifesciences Corporation $837K
11,250 sh × $74.40
Exec May 9 2025
Filed May 9 2025 · 5:30 PM ET EWSALE Edwards Lifesciences Corporation $797K
11,250 sh × $70.87
Exec Mar 26 2025
Filed Mar 26 2025 · 5:30 PM ET EWSALE Edwards Lifesciences Corporation $796K
11,250 sh across 2 lots
Exec Feb 28 2025
Filed Feb 28 2025 · 5:30 PM ET EWSALE Edwards Lifesciences Corporation $852K
11,250 sh × $75.76
Exec Feb 13 2025
Filed Feb 13 2025 · 5:30 PM ET